Class / Patent application number | Description | Number of patent applications / Date published |
604285000 | Treating material insert retained in body orifice | 38 |
20090192474 | DELIVERY SYSTEM - A covering for delivering a substance or material to a surgical site is provided. The covering, with substance provided therein, may be referred to as a delivery system. Generally, the covering may be a single or multi-compartment structure capable of at least partially retaining a substance provided therein until the covering is placed at a surgical site. Upon placement, the covering may facilitate transfer of the substance or surrounding materials. For example, the substance may be released (actively or passively) to the surgical site. The covering may participate in, control, or otherwise adjust, the release of the substance. | 07-30-2009 |
20090275902 | FLUID DELIVERY SYSTEM FOR SURGICAL INSTRUMENTS - There is provided a penetratable toothed fastener for clamping tissue during surgery. The toothed fastener includes first and second legs each having longitudinal rows of transverse teeth and a securing member configured to pass through the transverse teeth to hold first and second legs closed relative to each other and about tissue. A locking mechanism is provided to retain the securing member within the first and second legs of the toothed fastener. The toothed fastener additionally includes receptacles for the receipt of medicant materials and holes in the teeth to dispense the materials to clamped tissue. | 11-05-2009 |
20090275903 | STENT FOR IRRIGATION AND DELIVERY OF MEDICATION - A stent comprises a flexible tube having a proximal end, a distal end, and a passageway extending from said proximal end toward said distal end. A first generally straight tube segment extends from the proximal end while a first generally curved segment extends from an end region of the first generally straight tube segment disposed away from the proximal end of the stent. A second generally straight tube segment extends from an end region of the first curved segment away from the first generally straight tube segment and is arranged at an acute angle relative to the first generally straight tube segment. A second generally curved tube segment extends from one end of the second generally straight tube segment and includes a channel on an exterior surface of the second generally curved tube segment. The first generally curved tube segment and the second generally straight tube segment further include at least one cavity irrigation hole extending from the tube passageway, for providing irrigation fluids into the cavity into which the stent is inserted. At least one segments includes a channel on an exterior surface. The channel is sized to serve as a reservoir to contain a predetermined amount of at least one form of medication for delivery, over a period of time, of the medication to a cavity region proximate which the stent has been inserted. | 11-05-2009 |
20100274204 | LACRIMAL IMPLANTS AND RELATED METHODS - Lacrimal implants and related methods providing secure, wedgable retention within a lacrimal punctum and associated canaliculus of an eye are disclosed. The lacrimal implants can comprise an implant body configured for at least partial insertion through the lacrimal punctum and into the canaliculus. The implant body can include first and second portions, and can extend from a proximal end of the first portion defining a longitudinal proximal axis to a distal end of the second portion defining a longitudinal distal axis. The implant body can be configured such that, when implanted using an integral dilator, an angled intersection exists between the proximal and distal axes. In this way, at least a portion of the implant body can be biased against at least a portion of the lacrimal canaliculus located at or more distal to a canalicular curvature, thereby retaining an implanted position of the lacrimal implant using anatomical structures. | 10-28-2010 |
20100286628 | GASTRIC ANCHOR - A swallowable medical treatment device is configured to initially assume a contracted state having a volume of less than 4 cm3. The device includes a gastric anchor, which initially assumes a contracted size, and which is configured to, upon coming in contact with a liquid, expand sufficiently to prevent passage of the gastric anchor through a round opening having a diameter of between 1 cm and 3 cm. The device also includes a duodenal unit, which is configured to pass through the opening, and which is coupled to the gastric anchor such that the duodenal unit is held between 1 cm and 20 cm from the gastric anchor. Other embodiments are also described. | 11-11-2010 |
20110054418 | Methods and apparatus for pulsatile release of medicaments from a punctal plug - This invention discloses methods and apparatus for providing pulsatile release of active agents via a punctal plug inserted into a punctum. A tube is provided which may be inserted into a cavity of a punctal plug. One or more pulsatile delivery units are arranged in a generally linear fashion within the tube. The pulsatile delivery units include a core comprising the active agent and an encapsulation layer around the core. | 03-03-2011 |
20110208135 | INTRAVAGINAL DELIVERY SYSTEM AND PROCESS FOR MANUFACTURING IT - The present invention concerns an intravaginal delivery system, said system comprising at least one compartment comprising a core and a membrane encasing the core, wherein the core and the membrane essentially consist of a same or different polymer composition. Additionally the intravaginal delivery system comprises a coupling means to form a closed continuous delivery system. The present invention also concerns a method for manufacturing said intravaginal delivery system. The core and/or the membrane are preferably prepared by injection moulding or by extrusion. | 08-25-2011 |
20110288501 | Methods Of Manufacturing A Medicated Tampon Assembly - A method is provided for manufacturing a medicated tampon assembly having a tampon body, the method including applying a formulation including a therapeutic agent to a substrate to produce a plurality of dosage forms; separating one of the dosage forms from the substrate; and coupling one of the dosage forms to the tampon body. A medicated tampon assembly is provided including a dosage form including a formulation including a therapeutic agent; a substrate portion separated from a substrate, wherein the substrate portion is coupled to the dosage form; and a tampon body having a distal end, wherein the substrate portion is coupled to the distal end of the tampon body. | 11-24-2011 |
20120065598 | TAMPON, A MANUFACTURING METHOD FOR A TAMPON, AND A MANUFACTURING APPARATUS FOR A TAMPON - A tampon has an absorbent body that absorbs liquid. On an outer surface of the absorbent body, the absorbent body includes an applied portion to which an agent is applied and that includes at least two applied layer. The at least two applied layer includes a first applied layer formed by applying a first agent, and a second applied layer formed by applying a second agent over the first applied layer, the first agent including active pharmaceutical ingredient and a first water-soluble carrier that carries the active pharmaceutical ingredient, the second agent including active pharmaceutical ingredient and a second water-soluble carrier that carries the active pharmaceutical ingredient and has a melting point lower than that of the first water-soluble carrier. | 03-15-2012 |
20120116325 | MEDICINAL DELIVERY DEVICE - A medicinal delivery device is provided. The device includes a clip defining an ala inner surface-engaging portion about a first end thereof. The clip also defines an ala outer surface-engaging portion about a second end thereof. The ala outer surface-engaging portion is in spaced-apart and generally inward facing arrangement relative to the first end of the clip. This forms a gap between the ala inner surface-engaging portion and the ala outer surface-engaging portion for receiving a patient's ala. A medicine chamber is carried about the first end of the clip for dispensing medicine into the patient's nasal cavity. | 05-10-2012 |
20120165761 | DRUG ELUTION THERAPY APPARATUS AND METHOD FOR TREATING BLOOD VESSELS - A drug therapy elution system and method for treating blood vessels. The system includes an enclosed receptacle containing the drug therapy for treating the damaged blood vessel. The system also includes one or more conduits that permit elution of the drug therapy from the enclosed receptacle into the damaged blood vessel wall. The system also includes one or more fixation mechanisms that can secure the enclosed receptacle to the blood vessel wall. | 06-28-2012 |
20130041331 | Modular Drug Delivery System for Minimizing Trauma During and After Insertion of a Cochlear Lead - A system for delivering a therapeutic agent to biological tissue includes a surgically implantable lead to be inserted into the biological tissue. The surgically implantable lead includes a preformed cavity. A modular capsule is configured to be retained within the preformed cavity. The modular capsule includes a first therapeutic agent and a second therapeutic agent, wherein the first therapeutic agent elutes rapidly into the biological tissue and the second therapeutic agent elutes more slowly into the biological tissue. | 02-14-2013 |
20130123716 | Vaginal Therapeutic Device Including Copper Metal - A vaginal therapeutic device having an exterior surface of copper metal that has a configuration for insertion in and retention in the vagina, and utilizes the copper metal as an antimicrobial agent to therapeutically treat abnormal biological conditions in the vagina. The exterior configuration of the device defines a plurality of protuberances to resist expulsion of the device from the vagina. | 05-16-2013 |
20130150810 | INTRAVAGINAL RING FOR THE DELIVERY OF UNIQUE COMBINATIONS OF ANTIMICROBIAL COMPOSITIONS - Disclosed are compositions for inhibiting transmission of a sexually transmitted infection that contain one or more polyanionic microbicides, such as carrageenans, including lambda carrageenan, as well as water-soluble metal salts and specified antiretroviral agents comprising NNRTIs and NRTIs. Also disclosed are methods for making and using the compositions. Also disclosed are intravaginal rings for delivering water-soluble compounds, and preferably high molecular weight water-soluble polymers at essentially a zero order rate. The rings include an outer layer of non-water-swellable elastomer, and preferably high molecular weight water-soluble polymer and an inner layer of the water-soluble polymer, which is imbedded in the outer layer, and an aperture through the outer layer for release thereof only through that aperture. | 06-13-2013 |
20130226104 | Devices, systems, and methods to control stomach volume - Embodiments disclosed herein relate to methods, devices, and computer systems thereof for reducing stomach volume in a subject. In certain embodiments, a subject receives a stomach-volume-reducing device that optionally includes at least one reservoir configured to release at least one appetite suppressant. In an embodiment, the stomach-volume-reducing device is responsive to one or more environmental conditions of the subject, for example, pH or chemical chemicals in the stomach of the subject. In an embodiment, the stomach-volume-reducing device controls hunger in the subject. | 08-29-2013 |
20130296809 | Nasal Congestion, Obstruction Relief, and Drug Delivery - A nasal insert may include a wall in the shape of a tube, the wall including a first end defining a first orifice and a second end defining a second orifice. The first end may have a diameter, diagonal measurement, or cross-sectional area larger than that of the second end. The first end may define at least one break in the wall, so that the first end incompletely encircles the first orifice. The second end may completely encircle the second orifice. | 11-07-2013 |
20140296798 | OCCLUSION DEVICE FOR CLOSING ANATOMICAL DEFECTS - An occlusion device for closing an anatomical defect in tissue comprising a conduit connecting an opening on a first tissue and an opening on a second tissue is provided. The occlusion device comprises a scaffold comprising a) a proximal support structure comprising at least two arms; b) a distal support structure comprising at least two arms, wherein the arms are adapted to provide anchorage for the device in the tissue; and c) a waist portion adapted for extending through the opening on the first tissue and connecting the proximal support structure with the distal support structure, wherein the scaffold consists essentially of a biodegradable polymer, wherein the proximal support structure and the distal support structure comprise or consist of polycaprolactone (PCL), poly-(D,L-lactide-co-caprolactone) (PLC), or a mixture thereof. A method of closing an anatomical defect using the occlusion device is also provided. | 10-02-2014 |
20140309597 | APPLICATOR FOR DELIVERING A SINGLE DOSE OF MEDICINE TO AN INNER CANAL OF AN EAR - An applicator for delivering a single dose of medicine into an inner canal of a person using a finger is disclosed. In one embodiment, the applicator includes a body having an open end and a closed end. A substantially solid compounded medicine is attached to the outer surface of the closed end of the body. The substantially solid compounded medicine melts to a liquid when disposed within the inner canal of the ear. A projection extends outwardly from the closed end of the body, with the compounded medicine surrounding the projection. | 10-16-2014 |
20140309598 | OSMOTICALLY ACTIVE VAGINAL DELIVERY SYSTEM - The present invention relates to the field of drug delivery systems. More particularly, the invention relates to osmotically active intravaginal delivery systems for the controlled release of therapeutically active substances to the vaginal cavity. | 10-16-2014 |
20140350488 | DRUG DELIVERY SYSTEM - The present invention provides a novel drug delivery system for the controlled release of therapeutically active substances at a predetermined, essentially constant release rate over a prolonged period of time. The delivery system comprises at least one core comprising said therapeutically active substance(s), at least one membrane encasing the core and an intermediary layer of a substantially inert material, wherein the intermediary layer is applied between the core and the membrane or between two membrane layers. | 11-27-2014 |
20160022487 | TREATMENT MEDIUM DELIVERY DEVICE AND METHODS FOR DELIVERY OF SUCH TREATMENT MEDIUMS TO THE EYE USING SUCH DELIVERY DEVICE - A device for delivering a treatment medium to an eye includes a first body portion configured to be removably inserted and secured in an opening of the eye, and a second body portion supported by the first body portion. At least the second body portion includes a treatment medium, and a coating having an opening through which the treatment medium elutes out of the device. | 01-28-2016 |
20160074640 | ATTACHABLE UTERINE DEVICE WITH INTEGRATED AND TIME RELEASE MEDICINAL ADMINISTERING COMPONENT AND INSERTION TOOL FOR IMPLANTING SUCH A DEVICE - A medicinal delivery device adapted to being applied to a surface of an internal organ and exhibiting a three dimensional shaped body with an outer shell and an inner medicinal composition which is released through an underside of the body in either of a dissolving or time release fashion. In one variant, a small plurality (typically between three and a dozen) of engagement prongs are integrally formed with the three dimensional shell and extend from its underside in order to secure the body to the organ. A related variant combines the delivery device with an implantation tool having forward end located gripping fingers actuated by a trigger to engage outer perimeter locations of the delivery device body. Upon location of the body in engaging contact with the organ, the fingers are reverse actuated to release the body during in situ implantation. | 03-17-2016 |
604286000 | Including foraminous material (e.g., sponge, etc.) or fibrous element other than withdrawal cord | 10 |
20090069758 | ENHANCED REMODELABLE MATERIALS FOR OCCLUDING BODILY VESSELS AND RELATED METHODS AND SYSTEMS - Described are methods, devices, and systems for occluding or ablating vascular vessels. Noninvasive procedures can be used to occlude and obliterate the greater saphenous vein, for example in the treatment of varicose vein condition caused by venous valve insufficiency. Further described is the cooperative use of an angiogenic remodelable material with one or more sclerosing agents to cause closure of a targeted bodily vessel. | 03-12-2009 |
20100121285 | MEANS FOR THE APPLICATION OF ACTIVE SUBSTANCES IN THE EAR CANAL OF A PATIENT - For applying medications in the form of active substances bound in a liquid or paste-like matrix in the ear canal, a means for absorbing and locally delivering a medication. The means includes a sack-like receptacle part in which a preferably textile tampon able to absorb the medication can be accommodated, and an elastic rubber retaining washer serving to fix the receptacle part in the outer ear. The receptacle part is firmly connected to a pulling device, such as a string, via the retaining washer. The retaining washer fixes the receptacle part in the outer ear canal and is thus supported on one side behind the anthelix and on the other side behind the tragus. In one embodiment, the retaining washer is made from a flat material stamped from foam rubber. The applicator can be sold with a charge of medication. | 05-13-2010 |
20110125109 | WOUND STICK - A device for introducing a haemostatic agent into a penetrating wound. The device includes an elongate introducing member and a haemostatic agent applied to the elongate introducing member. The haemostatic agent may be applied to the introducing member using a flexible membrane, configured to be rolled around the elongate introducing member, a biocompatible foam, or a gel. | 05-26-2011 |
20120071839 | TAMPON - A tampon has an absorbent body that absorbs liquid. The absorbent body includes, on its outer surface, an applied portion to which an agent is applied. The agent is a mixture of an active pharmaceutical ingredient, a first water-soluble carrier that carries the active pharmaceutical ingredient and is a main ingredient of the agent, and a second water-soluble carrier that carries the active pharmaceutical ingredient and has a melting point lower than that of the first water-soluble carrier. | 03-22-2012 |
20130030392 | APPLICATOR MEMBER AND FLEXIBLE RETENTION WEB DEVICE - A device and a method for manufacturing said device, the device comprising an applicator member and a flexible retention web ( | 01-31-2013 |
20130237933 | TAMPON STRUCTURE - The present invention relates to a tampon structure, the tampon structure comprise at least one absorbent carbonaceous base with at least two precious metals, an absorber, a surface layer, and a rope. The copper ions and silver ions can be released by the at least two precious metals in aqueous solution to reach the health effects of the female vagina. | 09-12-2013 |
20140142520 | IMPLANTABLE DEVICES INCLUDING A MESH AND A PIVOTABLE FILM - The present disclosure relates to implantable medical devices which include at least one mesh and at least one film pivotably attached to the mesh. | 05-22-2014 |
20140371687 | DEVICE HAVING TITANIA NANOTUBE MEMBRANE FOR DRUG DELIVERY - The present invention provides a device including a titania nanotube membrane having a plurality of titania nanotubes on a titanium substrate where the titania nanotubes are open at both ends and capable of allowing diffusion of liquids or solids from one side of the membrane to the other through the titania nanotubes. Methods of making the titania nanotube membrane are also provided. | 12-18-2014 |
20150011951 | DRUG DELIVERY SYSTEM USING IMPLANT - The present invention relates to an implant that is implanted into a human body by means of osseointegration. A drug delivery system comprises: an implant ( | 01-08-2015 |
20160184143 | DRUG DELIVERY DEVICE - The present invention relates to a device for insertion into a human or animal cavity, the device comprising an internally wearable plug comprising a pharmaceutically active composition; an externally wearable anchor element; and a sheath joining the plug to the anchor element such | 06-30-2016 |
604288000 | Soluble in body (e.g., suppository, etc.) | 6 |
20080262444 | Percutaneously Absorbable Preparation, Percutaneously Absorbable Preparation Holding Sheet, and Percutaneously Absorbable Preparation Holding Equipment - Self-dissolving needle-like or filamentous shape percutaneously absorbable preparations, by which inherently poorly absorbable drugs into the body through the skin is efficiently administered. The preparations are made of at least one material selected from the group consisting of proteins, polysaccharides, polyvinyl alcohols, carboxyvinyl polymers and sodium polyacrylic acids. An active substance contained therein is released in a sustained-release fashion (1) by forming a water-insoluble layer on its surface, (2) by holding the active substance in porous materials, or (3) by imparting a long-acting characteristic to the active substance. The present invention also provides a sheet-like carrier for holding the preparations on at least one of the sides thereof, and a piece of equipment for holding the preparations so as to facilitate the administration of them. | 10-23-2008 |
20100280464 | INTRAUTERINE SYSTEM - An intrauterine system is disclosed for use in the treatment of dysfunctional uterine bleeding; menorraghia; dysmenorrhoea; endometriosis; uterine fibroids; climacteric complaints; osteoporosis; and urogenital atrophy. The system is formed by a frame defining an interior space for receipt of a deposit of a therapeutically effective dose of a biologically active compound. The frame has an open structure allowing access to a substantial part of an outer surface of the deposit, and the deposit has a rate controlling structure that controls a rate of release of the compound within the uterus. One or more retention elements are provided on the frame for retaining the frame within the uterus of a female mammal. | 11-04-2010 |
20140171882 | INSTRUMENT FOR INSERTING A SUPPOSITORY - An instrument for inserting a suppository which includes a tube, having a first end adapted to receive the suppository and a second end, and a plunger disposed in the tube and moveable therein to eject the suppository from the first end by causing an action of pushing the suppository from behind. Retaining tongues are splayed outwards for ejection of the suppository in response to movement of the plunger in the tube, via contacting cooperation between at least one part of the plunger and at least one part of the tube. Securement mechanism secure the plunger in the tube at first position in which the suppository is retained in the first end of the tube, while allowing a user to move the plunger to actuate the instrument, and to secure the plunger in the tube at a second position which is only achievable after the plunger has been moved to eject the suppository. | 06-19-2014 |
20140296799 | Degradable Removable Implant for the Sustained Release of An Active Compound - A degradable, removable, pharmaceutical implant for the sustained release of one or more drugs in a subject, wherein the pharmaceutical implant is composed of a tube comprising an outer wall made of a degradable polymer completely surrounding a cavity, wherein the outer wall has a plurality of openings and wherein the cavity contains one or more sets of micro-particles, which micro-particles contain an active agent or a combination of two or more active agents, and wherein the size of the microparticles is selected such that the majority of the microparticles cannot pass through the openings. | 10-02-2014 |
20160199300 | CARBIDOPA/LEVODOPA GASTRORETENTIVE DRUG DELIVERY | 07-14-2016 |
20220134069 | DEVICE POSITIONABLE IN THE UTERINE CAVITY AND METHOD OF TREATMENT THEREOF - A delivery vehicle for a silver ion source such as silver nitrate and the like, suitable for use in the treatment of menorrhagia, comprises a plurality of beads bearing a tissue cauterizing amount of a silver ion source. In some embodiments, the silver ion source is silver nitrate, in combination with a binder of hydroxy propyl cellulose and a diluent of potassium nitrate. In some embodiments, the plurality of beads is useful in treating menorrhagia of a mammalian uterus. Silver ions are delivered in a sufficient amount to the endometrium to cause necrosis of the endometrial tissue. | 05-05-2022 |